Sriman Swarup Selected Research

Therapeutics

9/2020

Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sriman Swarup Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 09/2021 - 09/2020
1	Ischemia 01/2021
1	Monostotic Fibrous Dysplasia 12/2020
1	Thrombocytopenia (Thrombopenia) 12/2020
1	Venous Thromboembolism 09/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Polycythemia (Erythrocytosis) 01/2019

Drug/Important Bio-Agent (IBA)

1	ribociclibIBA 09/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2020
1	Hormones (Hormone)IBA 09/2020
1	Erythropoietin FDA Link 01/2019

Therapy/Procedure

1	Surgical Amputation (Amputations) 01/2021
1	Curettage 12/2020
1	Therapeutics 09/2020